Feed Insights Top Reports Pricing

⌘K

10:02:19·1401d

PRReleasevia Quantisnow

Renasant Corporation Declares Quarterly Dividend

ByQuantisnow·Wall Street's wire, on your screen.

RNST· Renasant Corporation

Finance

Plus alert sent

Quantisnow Plus members were alerted at 10:02:19 ET - 0.6s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment RNST files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNST (Renasant Corporation) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Engel Connie L sold $51,410 worth of shares (1,257 units at $40.90), decreasing direct ownership by 8% to 15,449 units (SEC Form 4)
Director Dale Albert J Iii sold $65,662 worth of shares (1,650 units at $39.80), decreasing direct ownership by 4% to 40,075 units (SEC Form 4)
Director Mcgraw Edward Robinson exercised 1,040 shares at a strike of $39.82 and covered exercise/tax liability with 385 shares, increasing direct ownership by 0.27% to 246,458 units (SEC Form 4)
Renasant Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Executive Vice Chairman Waycaster C Mitchell sold $501,808 worth of shares (12,704 units at $39.50), decreasing direct ownership by 6% to 183,235 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022